Chemomab Therapeutics (CMMB) Cash & Equivalents (2017 - 2026)
Chemomab Therapeutics (CMMB) posted Cash & Equivalents of $6 million for Q2 2026, up 7.2% from $5.6 million a year earlier and up 1.6% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, Chemomab Therapeutics' Cash & Equivalents came in at $7.56 million, up 24.6% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -8.3% (FY2020 to FY2025).
- In prior years, Chemomab Therapeutics' Cash & Equivalents was $6.07 million in FY2024 (-55.3%), $13.6 million in FY2023 (-10.8%), $15.24 million in FY2022 (unchanged) and $15.24 million in FY2021 (+30.6%).
- Quarterly Cash & Equivalents has run from a low of $4.67 million in Q1 2024 to a high of $37.74 million in Q3 2021 over five years.
- On a year-over-year basis, Cash & Equivalents increased in five of the last eight quarters, with growth averaging 1.7%.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q3 2021, with growth of 457.7%; the weakest was Q2 2022, with a decline of 78.1%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $5.91 million (Q1 2026), $7.56 million (Q4 2025) and $6.97 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Chemomab Therapeutics | 9.35 Mn | 9.35 Mn | - | 6.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.00 Mn |
| Mar 31, 2026 | 5.91 Mn |
| Dec 31, 2025 | 7.56 Mn |
| Sep 30, 2025 | 6.97 Mn |
| Jun 30, 2025 | 5.60 Mn |
| Mar 31, 2025 | 8.34 Mn |
| Dec 31, 2024 | 6.07 Mn |
| Sep 30, 2024 | 6.60 Mn |
| Jun 30, 2024 | 5.11 Mn |
| Mar 31, 2024 | 4.67 Mn |
| Dec 31, 2023 | 13.60 Mn |
| Sep 30, 2023 | 9.16 Mn |
| Jun 30, 2023 | 10.46 Mn |
| Mar 31, 2023 | 20.77 Mn |
| Dec 31, 2022 | 15.24 Mn |
| Sep 30, 2022 | 10.82 Mn |
| Jun 30, 2022 | 9.96 Mn |
| Mar 31, 2022 | 13.83 Mn |
| Dec 31, 2021 | 15.24 Mn |
| Sep 30, 2021 | 37.74 Mn |
API Access
Chemomab Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();